|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
230,290,000 |
Market
Cap: |
138.17(K) |
Last
Volume: |
11,847,187 |
Avg
Vol: |
11,814,847 |
52
Week Range: |
$0.0001 - $0.058 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kelso Equity Partners V L P |
10% Owner |
|
2005-10-12 |
4 |
S |
$26.04 |
$462,941,906 |
I/I |
(17,778,107) |
35,053,329 |
|
- |
|
Kelso Investment Assoc V L P |
10% Owner |
|
2005-10-12 |
4 |
OE |
$2.42 |
$44,283,434 |
I/I |
16,302,040 |
18,751,290 |
|
- |
|
Kelso Investment Assoc V L P |
10% Owner |
|
2005-10-12 |
4 |
S |
$26.04 |
$462,941,906 |
I/I |
(17,778,107) |
35,053,329 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-09-15 |
4 |
OE |
$2.42 |
$315,256 |
I/I |
98,720 |
48,731,032 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-09-15 |
4 |
OE |
$2.42 |
$341,787 |
I/I |
107,028 |
52,831,437 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-09-15 |
4 |
OE |
$2.42 |
$408,760 |
D/D |
128,000 |
63,184,284 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-08-09 |
4 |
OE |
$2.42 |
$20,531 |
I/I |
8,484 |
48,829,752 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-08-09 |
4 |
OE |
$2.42 |
$22,259 |
I/I |
9,198 |
52,938,464 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-08-09 |
4 |
OE |
$2.42 |
$26,620 |
D/D |
11,000 |
63,312,284 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-08-09 |
4 |
OE |
$2.42 |
$20,531 |
I/I |
8,484 |
48,829,752 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-08-09 |
4 |
OE |
$2.42 |
$22,259 |
I/I |
9,198 |
52,938,464 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-07-22 |
4 |
OE |
$2.42 |
$37,687 |
I/I |
13,463 |
48,838,236 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-07-22 |
4 |
OE |
$2.42 |
$40,860 |
I/I |
14,596 |
52,947,661 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-07-22 |
4 |
OE |
$2.42 |
$48,865 |
D/D |
17,456 |
63,323,284 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-07-22 |
4 |
OE |
$2.42 |
$37,687 |
I/I |
13,463 |
48,838,236 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-07-22 |
4 |
OE |
$2.42 |
$40,860 |
I/I |
14,596 |
52,947,661 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-05-27 |
4 |
OE |
$3.42 |
$263,768 |
I/I |
77,125 |
48,851,699 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-05-27 |
4 |
OE |
$3.42 |
$285,960 |
I/I |
83,614 |
52,962,257 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-05-27 |
4 |
OE |
$3.42 |
$342,000 |
D/D |
100,000 |
63,340,740 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-05-27 |
4 |
OE |
$3.42 |
$263,768 |
I/I |
77,125 |
48,851,699 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-05-27 |
4 |
OE |
$3.42 |
$285,960 |
I/I |
83,614 |
52,962,257 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-04-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
63,440,740 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-03-10 |
4 |
OE |
$2.42 |
$96,323 |
D/D |
38,871 |
63,440,740 |
|
- |
|
Lazar Michael B |
10% Owner |
|
2005-03-10 |
4 |
OE |
$2.42 |
$74,291 |
I/I |
29,980 |
48,928,824 |
|
- |
|
Lazar Michael B |
10% Owner |
|
2005-03-10 |
4 |
OE |
$2.42 |
$80,540 |
I/I |
32,502 |
53,045,872 |
|
- |
|
825 Records found
|
|
Page 28 of 33 |
|
|